V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10458522 | 10034765 | null | 94.6 | Curative (C) | 2019-11-08 | 2019-11-12 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | RITUXIMAB | 101017581 |
| 10458531 | 10034766 | 0 | 97 | Adjuvant (A) | 2021-01-03 | 2021-01-03 | CAPECITABINE + OXALIPLATIN | N | N | PEMBROLIZUMAB | 101782789 |
| 10458575 | 10034767 | 1.74 | 80.3 | Palliative (P) | 2019-04-11 | 2019-12-17 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101858700 |
| 10458598 | 10034768 | 1.55 | 87.6 | Palliative (P) | null | 2016-08-01 | Capecitabine + Oxaliplatin 14day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100180507 |
| 10458610 | 10034769 | 1.76 | 65.5 | Palliative (P) | 2018-11-19 | 2018-12-03 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101360085 |
| 10458671 | 10034770 | 1.62 | 122 | null | 2016-07-19 | 2016-08-01 | CAPECITABINE + OXALIPLATIN | null | null | CAPECITABINE | 100111518 |
| 10458731 | 10034771 | 1.7 | 104.9 | 03 | 2019-03-26 | 2019-03-26 | Capecitabine | 02 | N | CAPECITABINE | 101710007 |
| 10458775 | 10034772 | null | 41.2 | 03 | 2018-05-04 | 2018-05-17 | Capecitabine + Oxaliplatin 21day | 02 | N | IBRUTINIB | 101721080 |
| 10458778 | 10034773 | 1.6 | 72.2 | Curative (C) | 2018-10-27 | 2018-10-27 | IBRUTINIB | 02 | N | IBRUTINIB | 101164376 |
| 10458794 | 10034774 | 0 | 91 | Neo-adjuvant (N) | 2019-11-11 | 2019-11-18 | IBRUTINIB | 02 | Y | IBRUTINIB | 101188970 |
| 10458798 | 10034775 | 1.69 | 77 | Palliative (P) | 2018-07-01 | 2018-07-01 | IBRUTINIB | 02 | N | IBRUTINIB | 101163181 |
| 10458803 | 10034776 | 1.81 | 53 | Palliative (P) | 2020-01-01 | 2020-01-13 | Rituximab | 02 | N | RITUXIMAB | 101662074 |
| 10458823 | 10034777 | 1.5 | 76.8 | Adjuvant (A) | null | 2020-10-10 | Capecitabine + Oxaliplatin 21day | 02 | N | IBRUTINIB | 100757958 |
| 10458832 | 10034778 | 1.66 | 80 | 03 | 2017-04-13 | 2017-04-24 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE | 100517311 |
| 10458837 | 10034779 | 0 | 80 | Curative (C) | 2018-02-19 | 2018-02-21 | IBRUTINIB | 02 | N | IBRUTINIB | 101024818 |
| 10458845 | 10034780 | 0 | 104.8 | Neo-adjuvant (N) | 2018-07-08 | 2018-07-13 | IBRUTINIB | 02 | null | IBRUTINIB | 101761494 |
| 10458881 | 10034781 | 1.55 | 78.6 | 03 | 2020-04-08 | 2020-04-21 | Capecitabine + Oxaliplatin 21day | 02 | null | DOCETAXEL | 100050489 |
| 10458889 | 10034782 | 1.66 | 93 | Adjuvant (A) | 2018-10-06 | 2018-10-20 | Capecitabine + Oxaliplatin 21day | N | N | RITUXIMAB | 101279228 |
| 10458904 | 10034783 | 1.67 | 89.4 | null | 2020-10-10 | 2020-10-11 | CAPECITABINE + RT | 02 | null | CAPECITABINE | 100072211 |
| 10458907 | 10034784 | 1.74 | 50 | Adjuvant (A) | 2018-03-15 | 2018-04-17 | IBRUTINIB | 02 | N | IBRUTINIB | 100886186 |
| 10458908 | 10034785 | 1.75 | 56.9 | Adjuvant (A) | 2018-03-31 | 2018-04-19 | Rituximab | 02 | N | RITUXIMAB | 101584625 |
| 10458929 | 10034786 | 1.8 | 100.8 | 03 | 2021-04-04 | 2021-04-17 | PEMBROLIZUMAB | N | N | PEMBROLIZUMAB | 100198099 |
| 10458943 | 10034787 | null | 79.2 | Neo-adjuvant (N) | 2019-08-17 | 2019-08-23 | Rituximab | 02 | null | RITUXIMAB | 100257329 |
| 10458945 | 10034788 | 1.61 | 71.55 | Curative (C) | 2018-02-22 | 2018-02-25 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100557866 |
| 10458957 | 10034789 | null | 100 | null | 2017-04-20 | 2017-04-20 | Capecitabine + Oxaliplatin 21day | 02 | N | RITUXIMAB | 100793648 |
| 10458978 | 10034790 | null | 76.25 | Neo-adjuvant (N) | 2016-11-28 | 2017-04-12 | Rituximab | N | N | RITUXIMAB | 101453282 |
| 10458981 | 10034791 | 1.73 | 59.4 | Palliative (P) | 2020-01-28 | 2020-02-29 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100317274 |
| 10458989 | 10034792 | 1.62 | 84 | 03 | 2019-06-03 | 2019-06-09 | Rituximab (SUBCUTANEOUS Maintenance) | Y | N | RITUXIMAB | 100762681 |
| 10458993 | 10034793 | 1.78 | 81.5 | Adjuvant (A) | 2018-04-22 | 2018-05-17 | Capecitabine | 02 | N | CAPECITABINE | 100013799 |
| 10459003 | 10034794 | 1.74 | null | Palliative (P) | 2017-10-09 | 2017-10-09 | IBRUTINIB | 02 | N | IBRUTINIB | 100393675 |
| 10459014 | 10034795 | null | 50.8 | 03 | 2018-06-07 | 2018-06-07 | IBRUTINIB | 02 | N | IBRUTINIB | 100061457 |
| 10459023 | 10034796 | 1.7 | 69.8 | null | 2019-07-29 | 2019-09-24 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100769173 |
| 10459026 | 10034797 | 1.84 | 115.8 | Palliative (P) | 2013-12-25 | 2014-09-12 | Docetaxel | 02 | N | DOCETAXEL | 101824316 |
| 10459027 | 10034798 | 1.88 | 54.6 | null | 2020-01-19 | 2020-01-19 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101406305 |
| 10459072 | 10034799 | 1.69 | 85.7 | null | 2021-09-15 | 2021-09-22 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 101767587 |
| 10459125 | 10034800 | 1.54 | 68 | Curative (C) | 2018-10-14 | 2018-10-26 | IBRUTINIB | 02 | null | IBRUTINIB | 101277693 |
| 10459155 | 10034801 | 1.7 | 84.8 | null | 2021-04-09 | 2021-04-09 | Docetaxel | 99 | null | DOCETAXEL | 101606910 |
| 10459160 | 10034802 | 1.74 | 58 | Curative (C) | 2021-03-31 | 2021-04-02 | IBRUTINIB | 2 | N | IBRUTINIB | 101482253 |
| 10459163 | 10034803 | 1.67 | 79.5 | null | 2022-02-17 | 2022-02-24 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100778885 |
| 10459166 | 10034804 | 1.72 | 78.7 | null | 2020-07-02 | 2020-07-03 | Capecitabine | 02 | null | CAPECITABINE | 100116009 |
| 10459183 | 10034805 | 1.45 | 42 | Curative (C) | 2019-07-20 | 2019-08-16 | Rituximab | 02 | null | RITUXIMAB | 100153889 |
| 10459190 | 10034806 | 1.6 | 98.5 | Palliative (P) | 2016-09-06 | 2016-09-17 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101782560 |
| 10459201 | 10034807 | 1.76 | 75 | Neo-adjuvant (N) | 2018-05-08 | 2018-05-14 | Capecitabine + Oxaliplatin 21day | 02 | null | PEMBROLIZUMAB | 101731693 |
| 10459210 | 10034808 | null | 59.4 | Curative (C) | 2018-01-29 | 2018-02-10 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101392249 |
| 10459217 | 10034809 | 1.72 | 77.1 | null | 2021-06-04 | 2021-06-11 | CAPECITABINE + OXALIPLATIN | N | N | CAPECITABINE + OXALIPLATIN | 101528585 |
| 10459261 | 10034810 | 1.82 | 94 | Neo-adjuvant (N) | 2015-05-28 | 2015-05-28 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101485184 |
| 10459270 | 10034811 | 1.89 | 91.7 | Palliative (P) | 2016-11-03 | 2016-11-13 | Rituximab | 2 | null | RITUXIMAB | 101854361 |
| 10459288 | 10034812 | null | 78.4 | 03 | 2019-01-01 | 2019-01-02 | IBRUTINIB | 02 | N | IBRUTINIB | 100607229 |
| 10459290 | 10034813 | null | 81.2 | 03 | 2021-03-23 | 2021-04-10 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100344203 |
| 10459293 | 10034814 | 1.6 | 79 | Palliative (P) | 2018-05-18 | 2018-05-18 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101733350 |